Inhaled zanamivir for the prevention of influenza in families
Article Abstract:
The drug zanamivir can prevent influenza in people who come in contact with infected individuals and can also shorten the duration of illness in infected people. This was the conclusion of a study of 337 families in which one member contracted the flu.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections
Article Abstract:
The drug zanamivir seems to be effective in reducing the symptoms and duration of influenza when given as an intranasal spray. Researchers randomly assigned 262 patients with influenza to self-administer a placebo or zanamivir twice a day for five days via a nasal spray and inhalation therapy. In those who began treatment within 30 hours of the illness, zanamivir reduced the duration of symptoms from seven days to four. Overall, the drug alleviated symptoms one day sooner than the placebo. Zanamivir also reduced the amount of virus shed in nasal secretions.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
Zanamivir in the Prevention of Influenza Among Healthy Adults: A Randomized Controlled Trial
Article Abstract:
The drug zanamivir when inhaled once a day appears to be effective in preventing influenza. This drug inhibits the viral enzyme neuraminidase, which is essential for viral reproduction. Researchers randomly assigned 1107 healthy adults to inhale an aerosolized form of the drug or a placebo once a day for four weeks. Zanamivir was 67% effective in preventing influenza and did not have any serious side effects.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency
- Abstracts: Activation of the transcription factor NF-kappaB in the rat air pouch model of inflammation. Oxygen free radicals, inflammation, and synovitis: the current status
- Abstracts: Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misprostol versus surgical abortion
- Abstracts: Illness, not age itself, most often the trigger of sleep problems in older adults. Sleep Disorders, Often Unrecognized, Complicate Many Physical Illnesses
- Abstracts: Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV(sub)251 infection of macaques